1990

• Phoenix Scientific, Inc. is founded by a group of distributors to make bio-equivalent (generic) pharmaceuticals for private labeling.  By 1991, PSI completed the construction of its state-of-the-art GMP (good manufacturing process) plant.  In 1994, PSI would receive approval for its first Abbreviated New Animal Drug Application.
• 50 million U.S. households own one or more pets

1991

• "Durvet is focused on supplying more products to the market," declares President Bob Hormann, "20-30 new product lines per year is our goal.  Introducing products, maintaining flexibility in our operation and expanding our facilities symbolizes our long-term commitment to the animal healthcare market."

1994

• Durvet sales top $30 million

1995

• Durvet moved into its current modern facilities with 39,000 square feet of warehouse space

1997

• Advantage (TM) flea and tick control is introduced, igniting a marketing war as Bayer aims its advertising directly to pet owners (instead of veterinarians); promotional costs rise exponentially to more than $100 million
• Merial sues Phoenix Scientific, Inc. claiming its generic ivermectin infringes on their patent
• Durvet sales top $40 million

1999

• Durvet steps up diversification of its product line, getting more involved in the companion animal market while maintaining its commitment to its core business - livestock
• Merial and Phoenix settle their legal differences; Merial grants Phoenix the right to make its own 1% injectable ivermectin products

The 1990's Vital Statistics

• U.S. Population: 248,709,873
• Average Salary: $28,960
• Average Cost of Home: $123,000
• Life Expectancy:
  • Male: 73
  • Female: 80
• Average Consumer Costs:
  • New car: $16,000
  • Gallon of gas: $1.15
• National Debt:  $3.2 trillion, $5.4 trillion by 1999